skip to main content

News Archive

Date: 12/22/2014
By analyzing the DNA and RNA of lung cancers, researchers at the University of Michigan Rogel Cancer Center found that patients whose tumors contained a large number of gene fusions had worse outcomes than patients with fewer gene fusions.
Date: 12/19/2014
In a development that could lead to a deeper understanding of cancer and better early-stage treatment of the disease, University of Michigan researchers have devised a reliable way to grow a certain type of cancer cells from patients outside the body for study.
Date: 12/10/2014
Prostate cancer specialists at the University of Michigan Rogel Cancer Center are refining prostate cancer diagnosis to better identify those cancers that are more likely to grow quickly and spread to other parts of the body.
Date: 12/08/2014
Daniel F. Hayes, M.D., clinical director of the breast oncology program at the University of Michigan Rogel Cancer Center, was elected president of the American Society of Clinical Oncology, the largest and one of the most influential oncology professional societies.
Date: 12/02/2014
Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival, according to a new study from the University of Michigan Rogel Cancer Center.
Date: 11/19/2014
What’s the best way to treat rectal cancer? Consult any of five top clinical guidelines for rectal cancer and you will get a different answer, according to a new study by researchers at the University of Michigan Rogel Cancer Center.
Date: 11/18/2014
Patients who were told they had a 1-in-10 chance of winning $50 were more likely to complete home stool blood tests that help screen for colon cancer, according to a new study led by a researcher at the VA Ann Arbor Healthcare System and University of Michigan. The findings appear in a special issue of Annals of Internal Medicine.
Date: 11/11/2014
The Centers for Medicare and Medicaid announced Monday that lung cancer screening with CT scans will be covered for people at high-risk of developing lung cancer. The decision includes requirements to ensure quality and safety.
Date: 11/04/2014
New guidelines based on decades of clinical trials give guidance about which complementary therapies appear to be most effective and safe for breast cancer patients. More than 80 therapies were evaluated and assigned a letter grade.
Date: 10/31/2014
The University of Michigan men’s ice hockey team, in partnership with the University of Michigan Health System and the Movember Foundation, announced the second annual Michigan Moustaches for Men’s Health initiative during the month of November.

Pages